文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

难治性室速/室颤心脏骤停患者接受延长CPR与VA-ECMO期间的急性肺损伤与恢复

Acute lung injury and recovery in patients with refractory VT/VF cardiac arrest treated with prolonged CPR and veno-arterial extracorporeal membrane oxygenation.
PubMed 文献 · Resuscitation · 2022-11-25
一句话结论难治性室速/室颤院外心脏骤停接受VA-ECMO者肺损伤常见(91.8%),但影像严重程度与生存无关,肺顺应性恢复与生存相关。

该回顾性单中心队列研究纳入138例接受VA-ECMO辅助复苏的难治性室速/室颤院外心脏骤停患者,比较存活者、脑死亡者与其他原因死亡者的骤停特征、复苏后CT、呼吸机参数及肺相关病理。结果显示48/138(34.8%)存活,31/138(22.4%)脑死亡,59/138(42.7%)死于其他原因;91.8%(124/135)患者至少一个肺区存在肺损伤,主要位于依赖的后部区域,受累区域数与生存无关联。入院时肺顺应性低[26(19,33)ml/cmH2O],住院期间改善(p=0.03),存活者恢复更快(p<0.001)。VA-ECMO允许在维持正常化PaO2和PaCO2的同时使用肺保护性通气。

要点

  • 138例难治性VT/VF OHCA接受VA-ECMO者中,存活48/138(34.8%)、脑死亡31/138(22.4%)、其他原因死亡59/138(42.7%)。
  • 全部患者胸部CT显示至少一个肺区肺损伤者124/135(91.8%),以依赖的后部区域为主;受累区域数与生存无关联。
  • 入院时肺顺应性低[26(19,33)ml/cmH2O],住院期间改善(p=0.03),存活者较死亡者恢复更快(p<0.001)。
  • VA-ECMO允许在使用肺保护性通气的同时维持正常化PaO2和PaCO2。
  • 接受VA-ECMO联合IABP或Impella者较单纯VA-ECMO者肺顺应性更低、CT受累区域更多。

适用人群与场景

  • 难治性室速/室颤院外心脏骤停(VT/VF OHCA)并接受VA-ECMO辅助复苏的患者。

处置流程与药物剂量

  • VA-ECMO允许在使用肺保护性通气的同时维持正常化PaO2和PaCO2。

研究设计与关键结果

  • 回顾性单中心队列研究,纳入138例接受VA-ECMO辅助复苏的VT/VF OHCA患者,比较存活者、脑死亡者与其他原因死亡者的骤停特征、复苏后CT、呼吸机参数及其他肺相关病理。
  • 48/138(34.8%)存活,31/138(22.4%)发生脑死亡,59/138(42.7%)死于其他原因。
  • 39/138(28%)成功拔管,存活者中位拔管时间8.0天(6.0, 11.0)。
  • 存活者中15/48(31.3%)需要气管切开。
  • 全部患者胸部CT显示至少一个肺区肺损伤者124/135(91.8%),主要位于依赖的后部区域;受累区域数与生存无关联。
  • 入院时肺顺应性低[26(19,33)ml/cmH2O],住院期间改善(p=0.03),存活者较死亡者恢复更快(p<0.001)。
  • 接受VA-ECMO联合IABP或Impella者较单纯VA-ECMO者肺顺应性更低、CT受累区域更多。

证据类型、等级与局限

  • 证据类型:回顾性单中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,难治性VT/VF OHCA需要VA-ECMO者肺损伤常见,但影像严重程度与生存无关;肺顺应性下降伴随复苏后肺损伤,而顺应性恢复与生存相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Describe the lung injury patterns among patients presenting with refractory ventricular tachycardia/ventricular fibrillation out-of-hospital cardiac arrest (VT/VF OHCA) supported with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) facilitated resuscitation.

METHODS: In this retrospective single-center cohort study including VT/VF OHCA patients supported with VA ECMO, we compared OHCA characteristics, post-arrest computed tomography (CT) scans, ventilator parameters, and other lung-related pathology between survivors, patients who developed brain death, and those with other causes of death.

RESULTS: Among 138 patients, 48/138 (34.8%) survived, 31/138 (22.4%) developed brain death, and 59/138 (42.7%) died of other causes. Successful extubation was achieved in 39/138 (28%) with a median time to extubation of 8.0 days (6.0, 11.0) in those who survived. Tracheostomy was required in 15/48 (31.3%) survivors. Chest CT obtained on all patients showed lung injury in at least one lung area in 124/135 (91.8%) patients, predominantly in the dependent posterior areas. There was no association between the number of affected areas and survival. Lung compliance was low on admission [26 (19,33) ml/cmH20], improved throughout hospitalization (p = 0.03), and recovered faster in survivors compared to those who died (p < 0.001). VA-ECMO allowed the use of lung-protective ventilation while maintaining normalized PaO2 and PaCO2. Patients treated with V-A ECMO and either IABP or Impella had lower pulmonary compliance and more affected areas on their CT compared to those treated with V-A ECMO alone.

CONCLUSIONS: Lung injury is common among patients with refractory VT/VF OHCA requiring V-A ECMO, but imaging severity is not associated with survival. Reductions in lung compliance accompany post-arrest lung injury while compliance recovery is associated with survival.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Gutierrez A, Kalra R, Elliott AM, et al. Acute lung injury and recovery in patients with refractory VT/VF cardiac arrest treated with prolonged CPR and veno-arterial extracorporeal membrane oxygenation. Resuscitation. 2022. PMID: 36442595. doi:10.1016/j.resuscitation.2022.11.017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。